ArticleNPJ precision oncology2026

Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer.

David D Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.